RecruitingPhase 3NCT06959095Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 InflammationSponsor: GlaxoSmithKlineHenderson, NV · Las Vegas, NV · Reno, NV · +39 more sites
RecruitingPhase 3NCT07177339eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 InflammationSponsor: GlaxoSmithKlineHenderson, NV · Las Vegas, NV · Reno, NV · +39 more sites
RecruitingPhase not listedNCT06122077Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer ScreeningSponsor: Freenome Holdings Inc.Reno, NV · +35 more sites